XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Net revenue $ 1,911,191 $ 1,733,951 $ 1,779,759
Operating expenses:      
Practice salaries and benefits 1,297,477 1,193,940 1,180,759
Practice supplies and other operating expenses 100,472 90,690 95,911
General and administrative expenses 263,357 248,947 244,512
Gain on sale of building (7,280)
Depreciation and amortization 32,147 28,441 25,931
Transformational and restructuring related expenses 22,100 73,801 60,890
Total operating expenses 1,708,273 1,635,819 1,608,003
Income from operations 202,918 98,132 171,756
Investment and other income 13,652 17,913 3,686
Interest expense (68,722) (110,482) (118,928)
Loss on early extinguishment of debt (14,532)
Equity in earnings of unconsolidated affiliates 1,912 1,585 2,270
Total non-operating expenses (67,690) (90,984) (112,972)
Income from continuing operations before income taxes 135,228 7,148 58,784
Income tax provision (27,241) (16,728) (16,576)
Income (loss) from continuing operations 107,987 (9,580) 42,208
Income (loss) from discontinued operations 22,950 (786,908) (1,539,910)
Net income (loss) 130,937 (796,488) (1,497,702)
Net loss attributable to noncontrolling interest 27
Net income (loss) attributable to Mednax, Inc. $ 130,964 $ (796,488) $ (1,497,702)
Income (loss) from continuing operations:      
Basic $ 1.27 $ (0.11) $ 0.50
Diluted 1.26 (0.11) 0.50
Income (loss) from discontinued operations:      
Basic 0.27 (9.44) (18.44)
Diluted 0.27 (9.44) (18.33)
Net income (loss) attributable to Mednax, Inc.:      
Basic 1.54 (9.55) (17.94)
Diluted $ 1.53 $ (9.55) $ (17.83)
Weighted average common shares:      
Basic 84,832 83,395 83,495
Diluted 85,828 83,395 84,011